Elicio Therapeutics Stock Analysis

Elicio Stock Analysis Notes

About 26.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Elicio Therapeutics had 1:10 split on the 2nd of June 2023. To learn more about Elicio Therapeutics call Robert Connelly at 857-209-0050 or check out https://elicio.com.

Elicio Therapeutics Investment Alerts

Elicio Therapeutics Upcoming and Recent Events

Elicio Largest EPS Surprises

View All Earnings Estimates

Elicio Therapeutics Thematic Classifications

Elicio Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.58 M.

Elicio Profitablity

Management Efficiency

Elicio Therapeutics has return on total asset (ROA) of (0.968) % which means that it has lost $0.968 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5302) %, meaning that it created substantial loss on money invested by shareholders. Elicio Therapeutics' management efficiency ratios could be used to measure how well Elicio Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.36 in 2024. Return On Capital Employed is likely to rise to -1.95 in 2024. At this time, Elicio Therapeutics' Other Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.40 in 2024, whereas Total Assets are likely to drop slightly above 20.5 M in 2024.

Technical Drivers

As of the 5th of October, Elicio Therapeutics shows the Downside Deviation of 4.85, mean deviation of 3.9, and Coefficient Of Variation of 1139.91. Elicio Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Elicio Therapeutics Price Movement Analysis

Elicio Therapeutics Insider Trading Activities

Elicio Therapeutics Predictive Daily Indicators

Elicio Therapeutics Corporate Filings

Elicio Therapeutics Forecast Models

Elicio Therapeutics' time-series forecasting models are one of many Elicio Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elicio Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Elicio Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Elicio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Elicio Therapeutics. By using and applying Elicio Stock analysis, traders can create a robust methodology for identifying Elicio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Elicio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Elicio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Elicio Therapeutics stock analysis indicators help investors evaluate how Elicio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Elicio Therapeutics shares will generate the highest return on investment. By understating and applying Elicio Therapeutics stock analysis, traders can identify Elicio Therapeutics position entry and exit signals to maximize returns.

When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.